Precigen, Inc. (PGEN) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Precigen reported revenue of $9.7M, up 146.7% from $3.9M the year before. Net income was -$250.6M (a -2588.2% net margin), or -$1.37 per diluted share. Operating margin was -1141.1%. Operating activities generated -$87.8M of cash, leaving -$89.8M of free cash flow. At fiscal year end, Precigen held $155.5M in total assets against $134.6M in total liabilities, including $30.2M of cash and equivalents.
Open the full interactive Precigen financials → Quarterly statements, key ratios, valuation history and price charts.
Precigen Key Stats
| Share Price | $7.48 |
|---|---|
| Market Cap | $3.09B |
| Revenue YoY Growth | +146.7% |
| 52-Week Range | $3.10 – $8.56 |
| Shares Outstanding | 356.9 million (basic, 2026 Q2) |
Precigen Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $103.2M | $103.9M | $26.9M | $6.2M | $3.9M | $9.7M |
| Cost of Goods Sold | $0 | $0 | $0 | $0 | $0 | — |
| Gross Profit | $103.2M | $103.9M | $26.9M | $6.2M | $3.9M | — |
| Operating Income | -$35.2M | $103.9M | $26.9M | $6.2M | $3.9M | -$110.5M |
| Pre-Tax Income | -$103.9M | -$96.9M | -$80.0M | -$96.4M | -$128.0M | -$250.6M |
| Income Tax | -$82,000 | -$160,000 | -$189,000 | -$458,000 | -$1.8M | $3,000 |
| Net Income | -$170.5M | -$92.2M | $28.3M | -$95.9M | -$126.2M | -$250.6M |
| Diluted EPS | -$1.02 | -$0.47 | $0.14 | -$0.39 | -$0.47 | -$1.37 |
Precigen Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $2.9M | $5.9M | $23.3M | $55.0M |
| Net Income | -$146.3M | -$23.5M | -$7.9M | $20.1M |
| Diluted EPS | -$1.06 | -$0.08 | -$0.02 | $0.05 |
Precigen Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $51.8M | $42.9M | $4.9M | $7.6M | $29.5M | $30.2M |
| Current Assets | $148.9M | $156.6M | $118.2M | $68.8M | $102.4M | $115.2M |
| Total Assets | $314.6M | $359.9M | $216.0M | $151.0M | $145.3M | $155.5M |
| Current Liabilities | $42.1M | $34.6M | $78.6M | $23.0M | $21.5M | $37.3M |
| Total Long-Term Debt | $171.9M | $183.2M | $86.4M | — | — | $93.2M |
| Total Liabilities | $247.4M | $252.5M | $89.7M | $32.5M | $78.5M | $134.6M |
| Shareholders' Equity | $67.2M | $107.3M | $126.3M | $118.5M | $38.5M | $20.9M |
Precigen Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$77.0M | -$55.8M | -$65.0M | -$66.9M | -$68.2M | -$87.8M |
| Cash From Investing | $27.8M | -$74.5M | $226.4M | -$3.1M | -$20.7M | -$1.5M |
| Cash From Financing | $32.7M | $121.2M | -$155.3M | $29.6M | $110.6M | $90.0M |
| Free Cash Flow | -$84.5M | -$63.0M | -$70.0M | -$68.4M | -$76.8M | -$89.8M |
Figures from Precigen's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Precigen financials page for every line item.
Precigen Company Profile
| Ticker | PGEN |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Germantown, Maryland |
| Incorporated in | Virginia |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001356090 |
Frequently Asked Questions
What was Precigen's revenue in fiscal 2025?
Precigen (PGEN) reported revenue of $9.7M for fiscal 2025.
What is Precigen's annual revenue history?
Precigen's annual revenue by fiscal year: 2020: $103.2M; 2021: $103.9M; 2022: $26.9M; 2023: $6.2M; 2024: $3.9M; 2025: $9.7M.
What was Precigen's net income in fiscal 2025?
Precigen reported net income of -$250.6M for fiscal 2025.
What was Precigen's earnings per share (EPS) in fiscal 2025?
Precigen's diluted EPS was -$1.37 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Precigen generate in fiscal 2025?
Precigen generated -$89.8M of free cash flow in fiscal 2025.
What was Precigen's revenue last quarter?
In its most recent reported quarter (2026 Q2), Precigen reported revenue of $55.0M.
How much debt does Precigen have?
Precigen reported $93.2M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Precigen are outstanding?
Precigen reported a weighted average of 356.9 million basic shares outstanding in 2026 Q2.
What is Precigen's market cap?
Based on its latest closing price, Precigen (PGEN) has a market capitalization of about $3.09B.
When does Precigen's fiscal year end?
Precigen's fiscal year end, as registered with the SEC, is December 31.
Where is Precigen headquartered?
Precigen lists its business address in Germantown, Maryland in its SEC filings.